| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |